Kimberly-Clark Acquisition of Safeskin Completed
Safeskin Shareholders Approve Transaction
DALLAS, TX-The acquisition agreement signed in November 1999 between Kimberly-Clark Corporation and Safeskin Corporation has been approved by Safeskin shareholders. By approving the merger, Safeskin shareholders gave Kimberly-Clark entrance to the latex and synthetic glove market. Chairman and chief executive officer of Kimberly-Clark, Wayne R. Sanders, commented, "Safeskin has built one of the fastest growing, most technologically innovative and cost-effective businesses in the glove industry. We are pleased to complement our expanding offering of professional healthcare products with Safeskin gloves. With this acquisition, we will be able to offer a complete line of head-to-toe protection products for healthcare workers."
Valued at $800 million, the transaction includes issuing Safeskin shareholders .1956 of a share of Kimberly-Clark common stock for each share of Safeskin common stock. David R. Murray, president of Kimberly-Clark's professional healthcare sector will assume leadership of the Safeskin line and Richard Jaffe, chairman, president and chief executive officer of Safeskin will become a company consultant.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
